Page 17 - AN-3-4

Advanced Neurology LBD prevalence and incidence in India

Table 2. Quality assessment of one cohort study included in the review
Cohort studies Study name (year) ➤ Sanyal et al. (2014)
Questions ▼
1. Were the two groups similar and recruited from the same population? Yes
2. Were the exposures measured similarly to assign people to both exposed and unexposed groups? Yes
3. Was the exposure measured in a valid and reliable manner? Not applicable
4. Were confounding factors identified? Yes
5. Were strategies to deal with confounding factors stated? Yes
6. Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)? No
7. Were the outcomes measured in a valid and reliable manner? Yes
8. Was the follow-up time reported and sufficient for outcomes to occur? Yes
9. Was follow-up complete, and if not, were the reasons for the loss to follow-up described and explored? Yes
10. Were strategies to address incomplete follow-up utilized? Yes
11. Was appropriate statistical analysis used? Yes
Overall appraisal Include

Appendix 3. JBI modified the data extraction tool for this study
Reference - Munn et al. 16
Study details/Methods

• Study ID/record number is a numeric code to identify the study from which the effect size estimate was obtained.
• Study title – the full title of the study
• Author – This is an alphabetic or character code that is usually the first few characters of the primary study’s author
name, which serves as an easy way to identify the study in the bibliography.
• Year of publication
• Journal – the journal in which the article was published.
• Type of study design
• Aims of the study – as stated in the report.
• Setting – may refer to a hospital, community, or aged care facility; rural/urban; primary/secondary/tertiary.
• Method of data analysis
• Follow-up or study duration – any details on the study duration or follow-up of the participants
Results
• Demographics – age at diagnosis, sex, state/city, sample size
• Cognitive score (MMSE, MoCA, ACE, etc.)
• DLB clinical symptoms
• What type of prevalence was measured?
• Diagnosis methods/criteria used.
• Screening methods
• Prevalence n/N (%) – Living with dementia, LBD, and non-LBD
• Proportion and 95% confidence intervals
• Incidence n/N (%) – Newly diagnosed dementia, LBD, and non-LBD
Number of individuals with PD diagnosed with PDD
• Proportion and 95% confidence intervals
• Findings

Appendix 4. JBI data extraction tool (prevalence and incidence)
Reference - Munn et al. 16

Volume 3 Issue 4 (2024) 11 doi: 10.36922/an.4098